Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration

Heart

Volumn 78, Issue 1, 1997, Pages 44-49

  Cecchi, Franco ^a,c   Montereggi, Alessio ^a   Olivotto, Iacopo ^a   Marconi, Paolo ^a   Dolara, Alberto ^a   Maron, Barry J ^b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c NONE   (Italy)

Author keywords

Atrial fibrillation; Hypertrophic cardiomyopathy; Prognosis; Signal averaged ECG

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; P WAVE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SINUS RHYTHM;

EID: 0030747674     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.1.44     Document Type: Article

References (27)

1. Maron BJ, Bonow RO, Cannon RO, Leon BM, Epstein SE. Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987;316:780-9,844-52.
2. Robinson KC, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol 1990;15:1279-85.
3. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, et al. Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophy - a review. Progr Cardiovasc Dis 1985;28:1-83.
4. Spirito P, Lakatos E, Maron BJ. Degree of left ventricular hypertrophy in chronic atrial fibrillation in hypertrophic cardiomyopathy. Am J Cardiol 1992;69:1217-22.
5. Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood DR, Itscoitz SB, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976;53:273-9.
6. Glancy DL, O'Brien KP, Gold HK, Epstein SE. Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis. Br Heart J 1970;32:652-9.
7. Stafford WJ, Trohman RG, Bilsker M, Zaman L, Castellanos A, Myerburg RJ. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;7:701-4.
8. Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995;26:1529-36.
9. Madariaga I, Carmona JR, Mateas FR, Lezaun R, de los Arcos E. Supraventricular arrhythmia as the cause of sudden death in hypertrophic cardiomyopathy. Eur Heart J 1994;15:134-7.
10. Maia IG, Filho FESC, Fagundes MLA, Boghossian SH, Vanheusden L, Sa RM, et al. Signal-averaged P wave in patients with Wolff-Parkinson-White syndrome after successful radiofrequency catheter ablation. J Am Coll Cardiol 1995;26:1310-14.
11. Fukunami M, Yamada T, Ohmori M, Kumagai K, Umemoto K, Sakai A, et al. Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram. Circulation 1991;83:162-9.
12. Guidera SA, Steinberg JS. The signal-averaged P wave duration: a rapid and noninvasive marker of risk of atrial fibrillation. J Am Coll Cardiol 1993;21:1645-51.
13. Stafford PJ, Turner I, Vincent R. Quantitative analysis of signal-averaged P waves in idiopathic paroxysmal atrial fibrillation. Am J Cardiol 1991;68:751-5.
14. Steinberg JS, Zelenkofske S, Wong SC, Gelernt M, Sciacca R, Menchavez E. Value of signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation 1993;88:2618-22.
15. Montereggi A, Marconi P, Olivotto I, Castelli G, Dolara A, Luisi ML, et al. Signal-averaged P wave duration and risk of atrial fibrillation in hyperthyroidism. Am J Cardiol 1996;77:266-9.
16. Marconi P, Montereggi A, Marioni C, Castelli G. Signal-averaged electrocardiogram in patients with paroxysmal lone atrial fibrillation. New Trends in Arrhythmias 1992;8: 277-81.
17. Marconi P, Montereggi A, Sarro F, Castelli G. "Signal averaging" dell'onda P: la problematica dell'allineamento del segnale. Cardiostimolazione 1993;11:135-8.
18. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 1979;43: 1242-4.
19. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of the distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide-angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 1981;48:418-28.
20. Sasson Z, Yock PG, Hatle LK, Alderman EL, Popp RL. Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy. J Am Coll Cardiol 1988:11:752-6.
21. Panza JA, Petrone RK, Fananapazir L, Maron BJ. Utility of continuous wave Doppler in noninvasive assessment of the left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1992;19:91-9.
22. Simson MB. Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction. Circulation 1981;64:235-42.
23. Scott WA, Donnerstein RL. Alignment of P waves for signal averaging. PACE 1990;13:1559-62.
24. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley, 1989.
25. Janse MJ, Allessie MA. Experimental observations in atrial fibrillation. In: Falk RH, Podrid PJ, eds. Atrial fibrillation: mechanism and management. New York: Raven Press; 1992:41-58.
26. Ohe T, Matsuhisa M, Kamakura S, Yamada J, Sato I, Nakajima K, et al. Relation between the widening of the fragmented atrial activity zone and atrial fibrillation. Am J Cardiol 1983;53:1219-22.
27. Maron BJ, Roberts WC. Hypertrophic cardiomyopathy. In: Schlant RC, Alexander RW, eds. Hurst's The heart, 8th ed, chapter 90. Baltimore: McGraw-Hill, 1994:1621-35.